Eintrag weiter verarbeiten
Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study
Gespeichert in:
| Zeitschriftentitel: | Journal of Global Oncology |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , , , , |
| In: | Journal of Global Oncology, 2019, 5, S. 1-9 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society of Clinical Oncology (ASCO)
|
| Schlagwörter: |
| author_facet |
Dano, Domitille Hénon, Clémence Sarr, Ousseynou Ka, Kanta Ba, Mouhamadou Badiane, Awa Thiam, Ibrahima Diene, Papa Diop, Mamadou Dem, Ahmadou Marino, Patricia Mancini, Julien Annede, Pierre Gonçalves, Anthony Diouf, Doudou Monneur, Audrey Dano, Domitille Hénon, Clémence Sarr, Ousseynou Ka, Kanta Ba, Mouhamadou Badiane, Awa Thiam, Ibrahima Diene, Papa Diop, Mamadou Dem, Ahmadou Marino, Patricia Mancini, Julien Annede, Pierre Gonçalves, Anthony Diouf, Doudou Monneur, Audrey |
|---|---|
| author |
Dano, Domitille Hénon, Clémence Sarr, Ousseynou Ka, Kanta Ba, Mouhamadou Badiane, Awa Thiam, Ibrahima Diene, Papa Diop, Mamadou Dem, Ahmadou Marino, Patricia Mancini, Julien Annede, Pierre Gonçalves, Anthony Diouf, Doudou Monneur, Audrey |
| spellingShingle |
Dano, Domitille Hénon, Clémence Sarr, Ousseynou Ka, Kanta Ba, Mouhamadou Badiane, Awa Thiam, Ibrahima Diene, Papa Diop, Mamadou Dem, Ahmadou Marino, Patricia Mancini, Julien Annede, Pierre Gonçalves, Anthony Diouf, Doudou Monneur, Audrey Journal of Global Oncology Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study Oncology Cancer Research |
| author_sort |
dano, domitille |
| spelling |
Dano, Domitille Hénon, Clémence Sarr, Ousseynou Ka, Kanta Ba, Mouhamadou Badiane, Awa Thiam, Ibrahima Diene, Papa Diop, Mamadou Dem, Ahmadou Marino, Patricia Mancini, Julien Annede, Pierre Gonçalves, Anthony Diouf, Doudou Monneur, Audrey 2378-9506 American Society of Clinical Oncology (ASCO) Oncology Cancer Research http://dx.doi.org/10.1200/jgo.19.00106 <jats:sec><jats:title>PURPOSE</jats:title><jats:p> The prevalence of breast cancer is increasing in low- to middle-income countries such as Senegal. Our prospective study assessed the quality of life (QoL) of patients with breast cancer undergoing chemotherapy in Senegal. </jats:p></jats:sec><jats:sec><jats:title>PATIENTS AND METHODS</jats:title><jats:p> Our study included women with breast cancer undergoing chemotherapy as initial treatment at the Center Aristide Le Dantec University Hospital in Dakar. Clinical, sociodemographic, and QoL data were collected and analyzed at three different times: baseline, 3 months, and 6 months after the start of systemic therapy. Health-related QoL was assessed using a Functional Assessment of Cancer Therapies-Breast (FACT-B) questionnaire after translation into the Wolof language. Linear mixed-effects models were performed to assess the changes in QoL scores. </jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p> Between July 2017 and February 2018, 120 patients were included in the study. Their median age was 45 years. Most patients (n = 105; 92%) had locally advanced disease (T3 to T4 stage) and lymph node involvement (n = 103; 88%), and half had metastatic disease. The FACT-B total scores significantly improved over time (β = 1.58; 95% CI, 0.50 to 2.67; P < .01). Nausea and vomiting were significantly associated with a decrease in FACT-B total scores (β = −16.89, 95% CI, −29.58 to −4.24, P = .012; and β = −13.44, 95% CI, −25.15 to −1.72, P = .028, respectively). </jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p> Our study confirmed the feasibility of standardized QoL assessment in Senegalese patients with breast cancer. Our results indicated a potential improvement of QoL over the course of chemotherapy. Optimizing nausea and vomiting prevention may improve QoL. </jats:p></jats:sec> Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study Journal of Global Oncology |
| doi_str_mv |
10.1200/jgo.19.00106 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qZ28uMTkuMDAxMDY |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qZ28uMTkuMDAxMDY |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-105 DE-Ch1 DE-L229 |
| imprint |
American Society of Clinical Oncology (ASCO), 2019 |
| imprint_str_mv |
American Society of Clinical Oncology (ASCO), 2019 |
| issn |
2378-9506 |
| issn_str_mv |
2378-9506 |
| language |
English |
| mega_collection |
American Society of Clinical Oncology (ASCO) (CrossRef) |
| match_str |
dano2019qualityoflifeduringchemotherapyforbreastcancerinawestafricanpopulationindakarsenegalaprospectivestudy |
| publishDateSort |
2019 |
| publisher |
American Society of Clinical Oncology (ASCO) |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Global Oncology |
| source_id |
49 |
| title |
Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_unstemmed |
Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_full |
Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_fullStr |
Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_full_unstemmed |
Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_short |
Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_sort |
quality of life during chemotherapy for breast cancer in a west african population in dakar, senegal: a prospective study |
| topic |
Oncology Cancer Research |
| url |
http://dx.doi.org/10.1200/jgo.19.00106 |
| publishDate |
2019 |
| physical |
1-9 |
| description |
<jats:sec><jats:title>PURPOSE</jats:title><jats:p> The prevalence of breast cancer is increasing in low- to middle-income countries such as Senegal. Our prospective study assessed the quality of life (QoL) of patients with breast cancer undergoing chemotherapy in Senegal. </jats:p></jats:sec><jats:sec><jats:title>PATIENTS AND METHODS</jats:title><jats:p> Our study included women with breast cancer undergoing chemotherapy as initial treatment at the Center Aristide Le Dantec University Hospital in Dakar. Clinical, sociodemographic, and QoL data were collected and analyzed at three different times: baseline, 3 months, and 6 months after the start of systemic therapy. Health-related QoL was assessed using a Functional Assessment of Cancer Therapies-Breast (FACT-B) questionnaire after translation into the Wolof language. Linear mixed-effects models were performed to assess the changes in QoL scores. </jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p> Between July 2017 and February 2018, 120 patients were included in the study. Their median age was 45 years. Most patients (n = 105; 92%) had locally advanced disease (T3 to T4 stage) and lymph node involvement (n = 103; 88%), and half had metastatic disease. The FACT-B total scores significantly improved over time (β = 1.58; 95% CI, 0.50 to 2.67; P < .01). Nausea and vomiting were significantly associated with a decrease in FACT-B total scores (β = −16.89, 95% CI, −29.58 to −4.24, P = .012; and β = −13.44, 95% CI, −25.15 to −1.72, P = .028, respectively). </jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p> Our study confirmed the feasibility of standardized QoL assessment in Senegalese patients with breast cancer. Our results indicated a potential improvement of QoL over the course of chemotherapy. Optimizing nausea and vomiting prevention may improve QoL. </jats:p></jats:sec> |
| container_issue |
5 |
| container_start_page |
1 |
| container_title |
Journal of Global Oncology |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792328278700195842 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T12:50:19.331Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Quality+of+Life+During+Chemotherapy+for+Breast+Cancer+in+a+West+African+Population+in+Dakar%2C+Senegal%3A+A+Prospective+Study&rft.date=2019-12-01&genre=article&issn=2378-9506&issue=5&spage=1&epage=9&pages=1-9&jtitle=Journal+of+Global+Oncology&atitle=Quality+of+Life+During+Chemotherapy+for+Breast+Cancer+in+a+West+African+Population+in+Dakar%2C+Senegal%3A+A+Prospective+Study&aulast=Monneur&aufirst=Audrey&rft_id=info%3Adoi%2F10.1200%2Fjgo.19.00106&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792328278700195842 |
| author | Dano, Domitille, Hénon, Clémence, Sarr, Ousseynou, Ka, Kanta, Ba, Mouhamadou, Badiane, Awa, Thiam, Ibrahima, Diene, Papa, Diop, Mamadou, Dem, Ahmadou, Marino, Patricia, Mancini, Julien, Annede, Pierre, Gonçalves, Anthony, Diouf, Doudou, Monneur, Audrey |
| author_facet | Dano, Domitille, Hénon, Clémence, Sarr, Ousseynou, Ka, Kanta, Ba, Mouhamadou, Badiane, Awa, Thiam, Ibrahima, Diene, Papa, Diop, Mamadou, Dem, Ahmadou, Marino, Patricia, Mancini, Julien, Annede, Pierre, Gonçalves, Anthony, Diouf, Doudou, Monneur, Audrey, Dano, Domitille, Hénon, Clémence, Sarr, Ousseynou, Ka, Kanta, Ba, Mouhamadou, Badiane, Awa, Thiam, Ibrahima, Diene, Papa, Diop, Mamadou, Dem, Ahmadou, Marino, Patricia, Mancini, Julien, Annede, Pierre, Gonçalves, Anthony, Diouf, Doudou, Monneur, Audrey |
| author_sort | dano, domitille |
| container_issue | 5 |
| container_start_page | 1 |
| container_title | Journal of Global Oncology |
| description | <jats:sec><jats:title>PURPOSE</jats:title><jats:p> The prevalence of breast cancer is increasing in low- to middle-income countries such as Senegal. Our prospective study assessed the quality of life (QoL) of patients with breast cancer undergoing chemotherapy in Senegal. </jats:p></jats:sec><jats:sec><jats:title>PATIENTS AND METHODS</jats:title><jats:p> Our study included women with breast cancer undergoing chemotherapy as initial treatment at the Center Aristide Le Dantec University Hospital in Dakar. Clinical, sociodemographic, and QoL data were collected and analyzed at three different times: baseline, 3 months, and 6 months after the start of systemic therapy. Health-related QoL was assessed using a Functional Assessment of Cancer Therapies-Breast (FACT-B) questionnaire after translation into the Wolof language. Linear mixed-effects models were performed to assess the changes in QoL scores. </jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p> Between July 2017 and February 2018, 120 patients were included in the study. Their median age was 45 years. Most patients (n = 105; 92%) had locally advanced disease (T3 to T4 stage) and lymph node involvement (n = 103; 88%), and half had metastatic disease. The FACT-B total scores significantly improved over time (β = 1.58; 95% CI, 0.50 to 2.67; P < .01). Nausea and vomiting were significantly associated with a decrease in FACT-B total scores (β = −16.89, 95% CI, −29.58 to −4.24, P = .012; and β = −13.44, 95% CI, −25.15 to −1.72, P = .028, respectively). </jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p> Our study confirmed the feasibility of standardized QoL assessment in Senegalese patients with breast cancer. Our results indicated a potential improvement of QoL over the course of chemotherapy. Optimizing nausea and vomiting prevention may improve QoL. </jats:p></jats:sec> |
| doi_str_mv | 10.1200/jgo.19.00106 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qZ28uMTkuMDAxMDY |
| imprint | American Society of Clinical Oncology (ASCO), 2019 |
| imprint_str_mv | American Society of Clinical Oncology (ASCO), 2019 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229 |
| issn | 2378-9506 |
| issn_str_mv | 2378-9506 |
| language | English |
| last_indexed | 2024-03-01T12:50:19.331Z |
| match_str | dano2019qualityoflifeduringchemotherapyforbreastcancerinawestafricanpopulationindakarsenegalaprospectivestudy |
| mega_collection | American Society of Clinical Oncology (ASCO) (CrossRef) |
| physical | 1-9 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | American Society of Clinical Oncology (ASCO) |
| record_format | ai |
| recordtype | ai |
| series | Journal of Global Oncology |
| source_id | 49 |
| spelling | Dano, Domitille Hénon, Clémence Sarr, Ousseynou Ka, Kanta Ba, Mouhamadou Badiane, Awa Thiam, Ibrahima Diene, Papa Diop, Mamadou Dem, Ahmadou Marino, Patricia Mancini, Julien Annede, Pierre Gonçalves, Anthony Diouf, Doudou Monneur, Audrey 2378-9506 American Society of Clinical Oncology (ASCO) Oncology Cancer Research http://dx.doi.org/10.1200/jgo.19.00106 <jats:sec><jats:title>PURPOSE</jats:title><jats:p> The prevalence of breast cancer is increasing in low- to middle-income countries such as Senegal. Our prospective study assessed the quality of life (QoL) of patients with breast cancer undergoing chemotherapy in Senegal. </jats:p></jats:sec><jats:sec><jats:title>PATIENTS AND METHODS</jats:title><jats:p> Our study included women with breast cancer undergoing chemotherapy as initial treatment at the Center Aristide Le Dantec University Hospital in Dakar. Clinical, sociodemographic, and QoL data were collected and analyzed at three different times: baseline, 3 months, and 6 months after the start of systemic therapy. Health-related QoL was assessed using a Functional Assessment of Cancer Therapies-Breast (FACT-B) questionnaire after translation into the Wolof language. Linear mixed-effects models were performed to assess the changes in QoL scores. </jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p> Between July 2017 and February 2018, 120 patients were included in the study. Their median age was 45 years. Most patients (n = 105; 92%) had locally advanced disease (T3 to T4 stage) and lymph node involvement (n = 103; 88%), and half had metastatic disease. The FACT-B total scores significantly improved over time (β = 1.58; 95% CI, 0.50 to 2.67; P < .01). Nausea and vomiting were significantly associated with a decrease in FACT-B total scores (β = −16.89, 95% CI, −29.58 to −4.24, P = .012; and β = −13.44, 95% CI, −25.15 to −1.72, P = .028, respectively). </jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p> Our study confirmed the feasibility of standardized QoL assessment in Senegalese patients with breast cancer. Our results indicated a potential improvement of QoL over the course of chemotherapy. Optimizing nausea and vomiting prevention may improve QoL. </jats:p></jats:sec> Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study Journal of Global Oncology |
| spellingShingle | Dano, Domitille, Hénon, Clémence, Sarr, Ousseynou, Ka, Kanta, Ba, Mouhamadou, Badiane, Awa, Thiam, Ibrahima, Diene, Papa, Diop, Mamadou, Dem, Ahmadou, Marino, Patricia, Mancini, Julien, Annede, Pierre, Gonçalves, Anthony, Diouf, Doudou, Monneur, Audrey, Journal of Global Oncology, Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study, Oncology, Cancer Research |
| title | Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_full | Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_fullStr | Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_full_unstemmed | Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_short | Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| title_sort | quality of life during chemotherapy for breast cancer in a west african population in dakar, senegal: a prospective study |
| title_unstemmed | Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study |
| topic | Oncology, Cancer Research |
| url | http://dx.doi.org/10.1200/jgo.19.00106 |